Effectiveness and Safety/Tolerability of Eslicarbazepine Acetate in Epilepsy Patients Aged ≥ 60 Versus < 60 Years: A Subanalysis from the Euro-Esli Study

INTRODUCTION: Clinical practice studies help guide antiepileptic drug (AED) therapy in patient groups routinely excluded from clinical trials, such as the elderly. The Euro-Esli study investigated the effectiveness and safety/tolerability of eslicarbazepine acetate (ESL) when used in everyday clinic...

Descripción completa

Detalles Bibliográficos
Autores principales: Lawthom, Charlotte, Bermejo, Pedro, Campos, Dulce, McMurray, Rob, Villanueva, Vicente
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6858887/
https://www.ncbi.nlm.nih.gov/pubmed/31098888
http://dx.doi.org/10.1007/s40120-019-0137-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6858887/
https://www.ncbi.nlm.nih.gov/pubmed/31098888
http://dx.doi.org/10.1007/s40120-019-0137-0

Ejemplares similares